CRY1 rs184039278: Understanding the Delayed Sleep Phase Variant
The CRY1 rs184039278 variant, also known as c.1657+3A>C, is a rare genetic change in the CRY1 gene associated with delayed sleep phase disorder (DSPD). This variant is thought to influence the body's internal clock, often resulting in a preference for later sleep and wake times.
What each genotype means
Typical circadian timing
You carry two copies of the standard allele and do not have the CRY1 splice alteration linked to familial delayed sleep phase disorder. Research indicates typical circadian clock function with no increased genetic predisposition to extended internal day length from this specific variant. Your sleep-wake schedule is likely influenced by other genetic and environmental factors.
Carried by the vast majority of individuals globally, representing over 99% of most populations.
Delayed sleep phase predisposition
You carry one copy of the c.1657+3A>C splice alteration in the CRY1 gene. Familial studies have linked this dominant change to delayed sleep phase disorder with sleep and wake times shifted later by approximately one to two hours, although larger population-based studies suggest the effect size may vary or be attenuated. This variant is associated with an extended circadian cycle and an evening chronotype, but it is not a standalone diagnosis.
Uncommon globally, found in approximately 0.3% to 0.6% of European ancestry individuals and slightly higher in certain cohorts such as Finnish or Turkish populations.
Delayed sleep phase predisposition
You carry two copies of the c.1657+3A>C splice alteration in the CRY1 gene. Because the altered splicing of exon 11 acts as a dominant gain-of-function change that lengthens the circadian cycle, carrying this variant is associated with a strong evening preference and delayed sleep onset. Due to the extreme rarity of individuals with two copies, precise clinical differences compared to carrying a single copy remain limited in published research.
Extremely rare across all surveyed global populations, with an estimated prevalence of less than 1 in 100,000 individuals.
What is the rs184039278 Variant?
The variant rs184039278, frequently referred to in scientific literature as CRY1 c.1657+3A>C, is a specific change in the DNA sequence of the CRY1 gene. Located on chromosome 12, this variant acts as a splice-site mutation. Specifically, it disrupts the normal processing of the gene's instructions, leading to the skipping of exon 11 during the creation of the CRY1 protein. This structural change results in a modified version of the protein that lacks an auto-inhibitory segment. Because this segment normally helps regulate the protein's activity, its absence creates a gain-of-function effect. This means the altered CRY1 protein remains active for longer than usual, which can interfere with the molecular machinery that keeps the human circadian rhythm—the body's internal 24-hour clock—synchronized with the external environment.
The Role of the CRY1 Gene
The CRY1 gene encodes the Cryptochrome Circadian Regulator 1 protein, a core component of the molecular circadian clock found in almost every cell of the human body. This protein functions as a transcriptional repressor, meaning it helps turn off the activity of other clock genes, such as CLOCK and BMAL1, at specific times of the day. By regulating these activator proteins, CRY1 helps maintain the precise timing of biological processes, including the sleep-wake cycle. When the CRY1 protein is functioning normally, it ensures that the circadian period remains stable. However, when the protein is altered—as is the case with the exon 11 deletion caused by the rs184039278 variant—its affinity for CLOCK and BMAL1 is enhanced. This increased binding strength effectively lengthens the molecular circadian period, which can manifest as a persistent delay in the timing of sleep onset and offset.
Research and Evidence
The association between rs184039278 and delayed sleep phase disorder (DSPD) was first identified in large, multigenerational families where the trait segregated with the variant. Research indicates that carriers of this variant often report a persistent and intractable delay in sleep timing relative to societal norms. While the evidence is strong for its role in familial cases, the impact in the general population is more nuanced. Some studies suggest that while the variant is associated with a shift toward later sleep times, the magnitude of this effect can vary significantly between individuals. Furthermore, while some research has explored potential links to other conditions like ADHD, these associations are still being investigated. It is important to note that having this variant does not guarantee a diagnosis of a sleep disorder, as environmental factors and other genetic modifiers also play critical roles in determining an individual's chronotype.
What You Can Do With This Information
Understanding your genetic status regarding rs184039278 can provide insight into why your natural sleep-wake cycle might differ from the societal norm. However, it is crucial to remember that this information is not a medical diagnosis. If you experience persistent sleep difficulties that impact your daily life, health, or well-being, you should consult with a healthcare professional or a sleep specialist. They can help evaluate your symptoms, provide a clinical assessment, and discuss evidence-based strategies for managing sleep phase issues, such as light therapy or behavioral adjustments. Never use genetic information to self-diagnose or to make changes to your medical care without professional guidance. Genetic variants are only one piece of a complex puzzle that includes your lifestyle, environment, and overall health history.
How common is this variant?
The rs184039278 variant is rare, with a global minor allele frequency of approximately 0.004, though it is more common in certain populations, such as the Ashkenazi Jewish population where frequencies can reach 0.03.
Frequently asked questions
Is rs184039278 the only cause of delayed sleep phase?
No, delayed sleep phase disorder is a complex condition influenced by many genetic and environmental factors. While this variant is a known contributor in some families, most cases of delayed sleep phase are likely caused by a combination of multiple genetic markers and lifestyle influences.
Does having this variant mean I have a sleep disorder?
Not necessarily. Genetic variants represent a predisposition rather than a definitive diagnosis. Many people with this variant may simply have a 'night owl' chronotype without meeting the clinical criteria for a sleep disorder.
Can I change my sleep cycle if I have this variant?
Yes, many individuals with delayed sleep phase can manage their sleep timing through behavioral interventions, such as controlled light exposure and consistent sleep hygiene. You should discuss these strategies with a sleep specialist to find an approach that works for your specific needs.
Should I get tested for this variant?
Genetic testing for this specific variant is generally not required for the clinical management of sleep issues. If you are concerned about your sleep, a consultation with a sleep specialist is the most effective first step, as they focus on your symptoms and overall health rather than just your genetic profile.
Sources & further reading
Educational information only, last refreshed 10/17/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs184751988?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CRY1
This intronic variant in the CRY1 gene is associated with delayed sleep-wake phase disorder (DSWPD) and has been linked to variations in glycemic parameters and insulin resistance.
This splice donor mutation (c.1657+1G>A) causes exon 11 skipping, leading to an overactive repressor complex and familial delayed sleep phase disorder.
Variant in the CRY1 gene, which encodes a core component of the circadian clock, associated with sleep timing and delayed sleep phase.
Variant in the CRY1 locus associated with sleep timing and circadian rhythm traits; distinct from rare high-penetrance mutations.
Cryptochrome 1 variant linked to sleep-wake timing variations and subjective poor sleep phenotypes.
This SNP is located in the CRY1 gene, which encodes a core circadian clock protein involved in regulating sleep-wake cycles.